510(k) K894359

CLOTRAC CITRATED WHOLE BLOOD COAGULATION CONTROLS by Hemotec, Inc. — Product Code JPA

K894359 is an FDA 510(k) premarket notification submitted by Hemotec, Inc. for the device "CLOTRAC CITRATED WHOLE BLOOD COAGULATION CONTROLS". The FDA issued a decision of Substantially Equivalent on September 5, 1989. The device falls under product code JPA (System, Multipurpose For In Vitro Coagulation Studies), a Class II device regulated under 21 CFR 864.5425. Hemotec, Inc. has at least 10 other 510(k) clearances on record.

Clearance Details

Decision
SESE (Substantially Equivalent)
Decision Date
September 5, 1989
Date Received
July 14, 1989
Clearance Type
Traditional
Expedited Review
No
Third Party Review
No

Device Classification

Device Name
System, Multipurpose For In Vitro Coagulation Studies
Device Class
Class II
Regulation Number
864.5425
Review Panel
HE
Submission Type